1. Potential antitumor agents. 50. In vivo solid tumour activity of derivatives of N-[2-(dimethylamino)ethyl]-acridine-4-car☐amide;Atwell;J Med Chem,1987
2. The experimental antitumour properties of three congeners of the acridinylmethanesulphonanilide (AMSA) series;Cain;Eur J Cancer,1974
3. Current status of amsacrine combination chemotherapy programs in acute leukemia;Arlin;Cancer Treat Rep,1983
4. Synthesis, antitumor activity and DNA binding properties of a new derivative of amsacrine N,5-dimethyl-9-((2-methoxy-4-methylsulfonylamino)phenylamino)-4-acridinecar☐amide;Baguley;Cancer Res,1984
5. A phase I trial of the amsacrine analog 9-[[2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino]-N,5-dimethyl-4-acridinecar☐amide (CI-921);Hardy;Cancer Res,1988